Commercialization: Page 93
-
PharmaVoice Team/PharmaVoice
PharmaOutlet
Direct to consumer advertising has received a great deal of attention in the past few years. No other market segment has received as much analysis, scrutiny, criticism, support, and debate as DTC. Along the way, the industry has also had the opportunity to learn a number of lessons to build upon ...
By Charles Hunt • March 19, 2008 -
PharmaVoice Team/PharmaVoice
PharmaCase
70 S e p t e mb e r 2003 PharmaVOICE For many phar maceu t i ca l ma r keters, the excite ment of launching a brand Website is short lived. Every thing that seemed so perfect, from the cre ative concept to the graphics and content,quickly comes under suspicion when monthly reports show little ret...
By PharmaVoice Team • March 19, 2008 -
PharmaVoice Team/PharmaVoice
The Great Divide
58 S e p t e mb e r 2003 PharmaVOICE ALL TOO OFTEN MARKETING AND R&D ARE AT ODDS ON HOW TO BEST ALLOCATE RESOURCES TO SUPPORT THE PIPELINE.THIS DISCONNECT BETWEEN SALES AND SCIENCE THREATENS THE FUTURE OF THE PHARMACEUTICAL INDUSTRY. The GREATDivide IN AN EXCLUSIVETO PHARMAVOICE, MICHAEL MENA...
By PharmaVoice Team • March 19, 2008 -
PharmaVoice Team/PharmaVoice
A Special Breed of Leader
12 S e p t e mb e r 2003 PharmaVOICE BREEDOFLEADER I got into this business with the ultimate objective to help people. I can’t think of a better way to begin every day. The minute I get in the car and start driving to work I get excited because I know what I am doing is ultimately going to make ...
By PharmaVoice Team • March 18, 2008 -
PharmaVoice Team/PharmaVoice
Global Opportunities
According to Ernst & Young, the sheer volume and growing economic muscle of consumers in emerging markets provide powerful investment incentives for multinational companies (MNCs). In particular, current and projected growth rates for pharmaceutical markets in the BRIC countries and Mexico ex...
By Robin Robinson • March 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
March 1718 3rd Imaging in Preclinical &Clinical Drug Development San Diego For more information, contact Vivian Frankel, GTCBio, at 6262566405, email [email protected], or visit gtcbio.com. March 1718 The Inaugural U.S.Conference on Comparator Studies Doubletree Hotel,Philadelphia For...
By PharmaVoice Team • March 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Edge Dynamics has added a flexible desktop module within its Demand Management Suite that offers lifesciences manufacturers a way to easily monitor and analyze channel activity data for their products. The Edge Dynamics Demand Dash...
By PharmaVoice Team • March 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES HealthEd Group has launched HealthEd Encore, which operates as a standalone agency, in response to increas ing client demand for educational patient marketing campaigns. HealthEd Encore offers a fullrange of ser vices, including c...
By PharmaVoice Team • March 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Best practices in planning and targeting and conducting office calls, as well as management of relationships, samples, programs, and salesforces are explored. These include the use of automated for mulary data and thoughtleader information to develop sales messages that anticipate formulary restr...
By PharmaVoice Team • March 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
There have been more than a few occasions when I felt I needed nothing short of a magic spell to get a client to run with an unconventional concept — the one that’s wonderfully unique while completely hitting the mark. The team at GSWWorldwide has done just that with their new “Itchcraft”campaign...
By PharmaVoice Team • March 2, 2008 -
PharmaVoice Team/PharmaVoice
The Fourth Tier: Tighter Control of Specialty Drugs
Managed MARKETS Managed care organizations are tackling the rising costs and expanding use of specialty products. Specialty drugs, injectable biologics, and other highercost drugs that require close supervision and monitoring are the fastest growing segment of the overall pharmaceutical space. Th...
By Denise Myshko • March 2, 2008 -
PharmaVoice Team/PharmaVoice
A Strategy for Pharma Diversification
In response to myriad challenges and with the hope of renewing double digit growth, the question becomes whether pharmaceutical firms should hold on to a pure pharmaceutical business model or embrace a more aggressive diversification strategy, says Roger Fournier, a senior executive working at a ...
By PharmaVoice Team • March 2, 2008 -
PharmaVoice Team/PharmaVoice
Ted Schroeder — A Thoughtful Note
BY KIM RIBBINK A THOUGHTFUL ote considered approach to leadership has helped Ted Schroeder guide his team through ups and downs and set Cadence Pharmaceuticals on a defined path, one in which a vibrant culture and strong core values are the keys to its longterm success. N A A Photography by natha...
By Kim Ribbink • March 2, 2008 -
PharmaVoice Team/PharmaVoice
A Woman's Heart
Women are six times more likely to die from heart attacks than breast cancer. Car diovascular diseases (CVD), particularly coronary heart disease (CHD) and stroke, remain the leading causes of death of women in America and most developed coun tries, with almost 39% of all female deaths in the Uni...
By Cynthia Borda • March 2, 2008 -
PharmaVoice Team/PharmaVoice
Climbing the Corporate Lattice
BY KIM RIBBINK executive search firm. “People need to be more prepared to work in a number of different companies or settings, including not just pharma but also specialty pharma and startup biotech.” This means there is tremendous movement in the industry, which presents challenges for companies...
By PharmaVoice Team • March 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Medicare Part D Results in INCREASED USE OF GENERIC DRUGS Generics accounted for more than half the drugs dispensed under Medicare’s Part D in its first six months of availability from January through June 2006. According to Generic Drug Utilization in the Medicare Part D Program, a report from t...
By PharmaVoice Team • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
For what seems like years, I have been attending continuing medical education (CME) meeting after CME meeting, reading article after article, listening to everyone qualified to have an opinion sharing his or her view. The topics and themes have remained the same. Quality improvement (QI) or perfo...
By Rick Kennison • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
HBA Leadership Conference
5th Annual HBA Leadership Conference 1 More than 500 industry leaders representing the Healthcare Businesswomen’s Association’s 10 chapters and three affiliates met in Washington,D.C., for an inspirational two?day conference, featuring a distinguished lineup of speakers and sessions. 2 4 7 1. Int...
By PharmaVoice Team • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
Developing a Formulary Formula
Managed MARKETS Experts on this Topic Sean Brandle. National Rx Practice Leader, The Segal Company, New York; The Segal Company is a private employee-owned actuarial and consulting firm. For more information, visit segalco.com. Larry Olson. VP and Practice Leader, Payer Markets, TNS Healthcare, N...
By PharmaVoice Team • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
Managing Investigator Initiated Trials
Investigator initiated trials (IITs) can be a valuable part of a pharmaceutical or medical device manufacturer’s marketing claims arsenal, according to Rita Numerof, Ph.D., president, and Mark Morgan, M.S., senior business analyst, at Numerof & Associates Inc. The two contend that IITs are re...
By PharmaVoice Team • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
Conquering the Divide — Joseph Pieroni
BY KIM RIBBINK Drawn initially to the lab as a medicinal chemist,then to the business side of pharma research, Joseph P. Pieroni has been able to straddle the often divided worlds of research and marketing seamlessly. This combination of skills and interests is great news for Daiichi Sankyo Inc.,...
By Kim Ribbink • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
MSLs: Evolution of Skills
The intent of the first MSL role, created in 1967 by the Upjohn Company, was to create a position within the pharmaceutical company that could interact with academiabased physicians and researchers. In the 1970s, the trend grew, with other companies mostly implementing MSL hir ing from within the...
By Robin Robinson • Jan. 30, 2008 -
PharmaVoice Team/PharmaVoice
Controlling the Message in Cyber Space and Time
Keeping Up With the 2.0 Joneses To maintain a competitive edge in today’s crowded environment,most experts believe the industry needs to step up its 2.0 practices or get left behind in a swirl of networking dust. Not only may early adopters get a marketing leg up on companies that choose to drag ...
By PharmaVoice Team • Jan. 29, 2008 -
PharmaVoice Team/PharmaVoice
Let the Games Begin
The influx of Gen-Xers and Yers into today’s workforce is pushing the industry’s conservative management leaders to play more games. Cutting-edge, fast-paced, highly competitive computer-based simulations and games designed to educate as they engage are gaining traction in the industry. The influ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Executive Appointments and Promotions Pharma POOL Aaron D. Berg Mark A. Glickman Oscient Names VPs to Head Key Growth Functions Oscient Pharmaceuticals, Waltham, Mass., has appointed two senior leaders with extensive cardiovascular experience. Aaron D. Berg has been named VP of marketing and Mark...
By PharmaVoice Team • Jan. 2, 2008
Previous
